Joannie Hui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joannie Hui has a total of 365 co-authors. Here are the top co-authors by number of shared publications:
- Nelson Leung Sang Tang
Department of Chemical Pathology, Prince of Wales Hospital, Hong Kong SAR, China
17 shared publications T.F. Fok
Department of Pediatrics, China
5 shared publicationsK.L. Cheung
Department of Pediatrics, China
4 shared publicationsL.K. Law
Department of Chemical Pathology, China
4 shared publicationsTai-Fai Fok
4 shared publicationsKa-Fai To
3 shared publications
Latest Publications
- 25 February 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (4) , e209779
Characterization of Factors Associated With Death in Deceased Patients With Mitochondrial Disorders
Mitochondrial disorders are multiorgan disorders resulting in significant morbidity and mortality. We aimed to characterize death-associated factors in an international cohort of deceased individuals with mitochondrial disorders. This cross-sectional multicenter observational study used data provided by 26 mitochondrial disease centers from 8 countries from January 2022 to March 2023. Individuals with genetically confirmed mitochondrial disorders were included, along with patients with clinically or genetically diagnosed Leigh syndrome. Collected data included demographic and genetic diagnosis variables, clinical phenotype, involvement of organs and systems, conditions leading to death, and supportive care. We defined pediatric and adult groups based on age at death before or after 18 years, respectively. We used Kruskal-Wallis with post hoc Dunn test with Bonferroni correction and Fisher exact test for comparisons, Spearman rank test for correlations, and multiple linear regression for multivariable analysis. Data from 330 deceased individuals with mitochondrial disorders (191 [57.9%] pediatric) were analyzed. The shortest survival times were observed in hepatocerebral syndrome (median 0.3, interquartile range [IQR] 0.2-0.6 years) and mitochondrial cardiomyopathy (median 0.3, IQR 0.2-5.2 years) and the longest in chronic progressive external ophthalmoplegia plus (median 26.5, IQR 22.8-40.2 years) and sensory ataxic neuropathy, dysarthria, and ophthalmoparesis (median 21.0, IQR 13.8-28.5 years). Respiratory failure and pulmonary infections were the most common conditions associated with death (52/330, 15.7% and 46/330, 13.9%, respectively). Noninvasive ventilation was required more often in children (57/191, 29.8%) than adults (12/139, 8.6%, p < 0.001), as was nasogastric or gastric tube (131/191, 68.6% in children and 39/139, 28.1% in adults, p < 0.001). On multivariate analysis, individuals with movement disorders and nuclear gene involvement had increased odds of any respiratory support use (OR 2.42 (95% CI 1.17-5.22) and OR 2.39 (95% CI 1.16-5.07), respectively). This international collaboration highlights the importance of respiratory care and infection management and provides a reference for prognostication across different mitochondrial disorders.
- 25 February 2025
- Published by Wolters Kluwer Health in Neurology
- Vol. 104 (4) , e209779
Characterization of Factors Associated With Death in Deceased Patients With Mitochondrial Disorders
Mitochondrial disorders are multiorgan disorders resulting in significant morbidity and mortality. We aimed to characterize death-associated factors in an international cohort of deceased individuals with mitochondrial disorders. This cross-sectional multicenter observational study used data provided by 26 mitochondrial disease centers from 8 countries from January 2022 to March 2023. Individuals with genetically confirmed mitochondrial disorders were included, along with patients with clinically or genetically diagnosed Leigh syndrome. Collected data included demographic and genetic diagnosis variables, clinical phenotype, involvement of organs and systems, conditions leading to death, and supportive care. We defined pediatric and adult groups based on age at death before or after 18 years, respectively. We used Kruskal-Wallis with post hoc Dunn test with Bonferroni correction and Fisher exact test for comparisons, Spearman rank test for correlations, and multiple linear regression for multivariable analysis. Data from 330 deceased individuals with mitochondrial disorders (191 [57.9%] pediatric) were analyzed. The shortest survival times were observed in hepatocerebral syndrome (median 0.3, interquartile range [IQR] 0.2-0.6 years) and mitochondrial cardiomyopathy (median 0.3, IQR 0.2-5.2 years) and the longest in chronic progressive external ophthalmoplegia plus (median 26.5, IQR 22.8-40.2 years) and sensory ataxic neuropathy, dysarthria, and ophthalmoparesis (median 21.0, IQR 13.8-28.5 years). Respiratory failure and pulmonary infections were the most common conditions associated with death (52/330, 15.7% and 46/330, 13.9%, respectively). Noninvasive ventilation was required more often in children (57/191, 29.8%) than adults (12/139, 8.6%, p < 0.001), as was nasogastric or gastric tube (131/191, 68.6% in children and 39/139, 28.1% in adults, p < 0.001). On multivariate analysis, individuals with movement disorders and nuclear gene involvement had increased odds of any respiratory support use (OR 2.42 (95% CI 1.17-5.22) and OR 2.39 (95% CI 1.16-5.07), respectively). This international collaboration highlights the importance of respiratory care and infection management and provides a reference for prognostication across different mitochondrial disorders.
- Open Access
- 23 April 2022
- Published by Hindawi Limited in Case Reports in Genetics
- Vol. 2022, 1-8
Kearns–Sayre Syndrome Minus: Two Cases of Identical Large-Scale Mitochondrial DNA Deletions with Presentations outside the Classical Triad
A curious triad of retinitis pigmentosa, external ophthalmoplegia, and complete heart block was presented by Sayre et al. in 1958. Since then, the disorder named KearnsSayre syndrome (KSS) has come to represent patients with mitochondrial DNA deletions presenting before adulthood, primarily with chronic progressive external ophthalmoplegia (CPEO) and pigmentary retinopathy. However, it is increasingly noted that the presentations can well be variable despite similar genetic deletions. Here, we present two cases with identical large-scale mitochondrial DNA deletions but very dissimilar outlook.
- 23 April 2022
- Published by Hindawi Limited in Case Reports in Genetics
- Vol. 2022, 1-8
Open AccessKearns–Sayre Syndrome Minus: Two Cases of Identical Large-Scale Mitochondrial DNA Deletions with Presentations outside the Classical Triad
A curious triad of retinitis pigmentosa, external ophthalmoplegia, and complete heart block was presented by Sayre et al. in 1958. Since then, the disorder named KearnsSayre syndrome (KSS) has come to represent patients with mitochondrial DNA deletions presenting before adulthood, primarily with chronic progressive external ophthalmoplegia (CPEO) and pigmentary retinopathy. However, it is increasingly noted that the presentations can well be variable despite similar genetic deletions. Here, we present two cases with identical large-scale mitochondrial DNA deletions but very dissimilar outlook.
- Open Access
- 1 September 2017
- Published by Hong Kong Academy of Medicine Press in Hong Kong Medical Journal
Expanded newborn metabolic screening programme in Hong Kong: a three-year journey
- 1 September 2017
- Published by Hong Kong Academy of Medicine Press in Hong Kong Medical Journal
Open AccessExpanded newborn metabolic screening programme in Hong Kong: a three-year journey
- Open Access
- 6 December 2016
- Published by Hong Kong Academy of Medicine Press in Hong Kong Medical Journal
- Vol. 22 (6) , 619-622
A common PRRT2 mutation in familial paroxysmal kinesigenic dyskinesia in Hong Kong: a case series of 16 patients
- 6 December 2016
- Published by Hong Kong Academy of Medicine Press in Hong Kong Medical Journal
- Vol. 22 (6) , 619-622
Open AccessA common PRRT2 mutation in familial paroxysmal kinesigenic dyskinesia in Hong Kong: a case series of 16 patients
- Open Access
- 7 October 2016
- Published by Hong Kong Academy of Medicine Press in Hong Kong Medical Journal
- Vol. 22 (5) , 506-508
One too many: intellectual disability secondary to undiagnosed phenylketonuria
- 7 October 2016
- Published by Hong Kong Academy of Medicine Press in Hong Kong Medical Journal
- Vol. 22 (5) , 506-508
Open AccessOne too many: intellectual disability secondary to undiagnosed phenylketonuria
- 21 October 2013
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 9 (4) , 361-364
Isolated persistent elevation of alanine transaminase for early diagnosis of pre-symptomatic Wilson’s disease in Chinese children
Background Recent studies presented a contradictory approach for the investigation of pediatric patients with an isolated increase in alanine transaminase. While classical teaching advised for a thorough investigation, recent studies suggested the yield on further investigation was low and thus not necessary. Yet the approach to the same clinical problem may need to be different due to variable disease prevalence rates among different ethnic populations. For the population with a higher prevalence rate of genetic liver diseases like Wilson’s disease, an abnormal liver function may be the first presenting feature for some patients. Methods We reviewed 10 Chinese children with Wilson’s disease who were diagnosed at a presymptomatic stage because of an isolated persistent elevation of alanine transaminase. Results All 10 patients did not have overt symptoms of liver impairment or neurological deficit. They were picked up incidentally with an abnormal liver function test. All patients were started on treatment shortly after diagnosis, and they remained well and symptom-free on the latest follow-up. Conclusions This case series illustrated that an isolated persistent elevation of alanine transaminase is an important clue to the early diagnosis of pre-symptomatic Wilson’s disease. It is particularly relevant in the Asian population where the disease is more prevalent.
- 21 October 2013
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 9 (4) , 361-364
Isolated persistent elevation of alanine transaminase for early diagnosis of pre-symptomatic Wilson’s disease in Chinese children
Background Recent studies presented a contradictory approach for the investigation of pediatric patients with an isolated increase in alanine transaminase. While classical teaching advised for a thorough investigation, recent studies suggested the yield on further investigation was low and thus not necessary. Yet the approach to the same clinical problem may need to be different due to variable disease prevalence rates among different ethnic populations. For the population with a higher prevalence rate of genetic liver diseases like Wilson’s disease, an abnormal liver function may be the first presenting feature for some patients. Methods We reviewed 10 Chinese children with Wilson’s disease who were diagnosed at a presymptomatic stage because of an isolated persistent elevation of alanine transaminase. Results All 10 patients did not have overt symptoms of liver impairment or neurological deficit. They were picked up incidentally with an abnormal liver function test. All patients were started on treatment shortly after diagnosis, and they remained well and symptom-free on the latest follow-up. Conclusions This case series illustrated that an isolated persistent elevation of alanine transaminase is an important clue to the early diagnosis of pre-symptomatic Wilson’s disease. It is particularly relevant in the Asian population where the disease is more prevalent.
- 1 September 2012
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 107 (1-2) , 136-144
Current diagnosis and management of mucopolysaccharidosis VI in the Asia-Pacific region
- 1 September 2012
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 107 (1-2) , 136-144
Current diagnosis and management of mucopolysaccharidosis VI in the Asia-Pacific region
- 27 August 2011
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 8 (3) , 278-280
The first reported HLCS gene mutation causing holocarboxylase synthetase deficiency in a Vietnamese patient
Holocarboxylase synthetase deficiency is an inborn error of biotin metabolism leading to multiple carboxylase deficiency which is often biotin responsive. This disease is believed to be relatively common among the Asian population.
- 27 August 2011
- Published by Springer Nature in World Journal of Pediatrics
- Vol. 8 (3) , 278-280
The first reported HLCS gene mutation causing holocarboxylase synthetase deficiency in a Vietnamese patient
Holocarboxylase synthetase deficiency is an inborn error of biotin metabolism leading to multiple carboxylase deficiency which is often biotin responsive. This disease is believed to be relatively common among the Asian population.
- 1 May 2011
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 84 (1001) , 469-477
Pictorial review of mucopolysaccharidosis with emphasis on MRI features of brain and spine
Mucopolysaccharidosis (MPS) is an inherited metabolic disorder of childhood, characterised by progressive multisystem involvement predominantly affecting the skeletal system leading to skeletal dysplasia. Mental retardation, neuropathy and cardiomyopathy may occur in the most severely affected patients, leading to progressive disability and death in their early third to fourth decades. The purpose of this paper is to illustrate the typical imaging features of different types of MPS, in particular the MR features of the brain and spine in MPS, which are expected to be encountered by radiologists more frequently in their clinical practice as a result of prolonged life expectancy for those with MPS with recent advances in therapeutic interventions. The treatment options and outcomes for MPS patients are also briefly discussed.
- 1 May 2011
- Published by Oxford University Press (OUP) in British Journal of Radiology
- Vol. 84 (1001) , 469-477
Pictorial review of mucopolysaccharidosis with emphasis on MRI features of brain and spine
Mucopolysaccharidosis (MPS) is an inherited metabolic disorder of childhood, characterised by progressive multisystem involvement predominantly affecting the skeletal system leading to skeletal dysplasia. Mental retardation, neuropathy and cardiomyopathy may occur in the most severely affected patients, leading to progressive disability and death in their early third to fourth decades. The purpose of this paper is to illustrate the typical imaging features of different types of MPS, in particular the MR features of the brain and spine in MPS, which are expected to be encountered by radiologists more frequently in their clinical practice as a result of prolonged life expectancy for those with MPS with recent advances in therapeutic interventions. The treatment options and outcomes for MPS patients are also briefly discussed.